On July 28, 2014, the U.S. House of Representatives passed legislation that would require the U.S. Food and Drug Administration (FDA) to speed up the review and approval process of ingredients in sunscreen products.
The Suncreen Innovation Act (H.R. 4250) was created in co-operation with the FDA and is the first major update to the review process since the 1990s.
The act allows any person to request that the Secretary of Health and Human Services (HHS) to determine whether an OTC sunscreen active ingredient or combination of ingredients is safe and effective.
The act also requires the Secretary to review any request regarding a sunscreen active ingredient or combination of ingredients that has been in use and that is not included in the stayed sunscreen monograph published by the FDA.